Log in | Register

Impact of macrolide therapy in critically ill patients with acute respiratory failure: a desirability of outcome ranking analysis to investigate the OUTCOMEREA database

Stéphanie Pons| Jean-François Timsit| Stéphane Ruckly| Carole Schwebel| Laurent Papazian| Elie Azoulay| Jean Reignier| Lara Zafrani
Online First ™ - March , 2019

Pages 1 - 3

No abstract available.


  1. Cigana C, Assael BM, Melotti P (2007) Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother 51:975–981. https://doi.org/10.1128/AAC.01142-06
    • View reference on publisher's website
  2. Kawamura K, Ichikado K, Takaki M et al (2016) Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis. SpringerPlus 5:1193. https://doi.org/10.1186/s40064-016-2866-1
    • View reference on publisher's website
  3. Walkey AJ, Wiener RS (2012) Macrolide antibiotics and survival in patients with acute lung injury. Chest 141:1153–1159. https://doi.org/10.1378/chest.11-1908
    • View reference on publisher's website
  4. Giamarellos-Bourboulis EJ, Pechère J-C, Routsi C et al (2008) Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis 46:1157–1164. https://doi.org/10.1086/529439
    • View reference on publisher's website
  5. Giacobbe DR, Signori A, Tumbarello M et al (2018) Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia. Eur J Clin Microbiol Infect Dis. https://doi.org/10.1007/s10096-018-3441-1

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement